Transcript downloaded - College of Business

Building
A
Knowledge Based Economy
(KBE)
* Money, Time and Talent !
History | KBE | Biomed | S&E | Talent | Enterprise
Map of Singapore:
Location of one-north
Nanyang Technological
University
Tuas
Biomedical Park
Changi
Airport
National University of S’pore
National University Hospital
Jurong Island
one-north
Biopolis
Fusionopolis
SGH
Seaport & Container
Terminals
City Centre
Singapore’s Economic Progress
Innovator of
new products
& services
KnowledgeIntensive
Technology-intensive
Capital-intensive
Skills-intensive
Labour-intensive
History | KBE | Biomed | S&E | Talent | Enterprise
The Turning Point
S$14,345
(1986)
GDP Per capita (S$)
25,000
1985/6
Recession
20,000
15,000
1987
Recovery
10,000
5,000
0
1965
1970
1975
Independence
1965
S$ 1,567
(1965)
History | KBE | Biomed | S&E | Talent | Enterprise
1980
1985
1985: Economy shrank 1.5%
1985: 4% unemployment
1986: 7% unemployment
1990
The UpTurn
S$46,832
(2006)
50,000
GDP Per capita (S$)
45,000
40,000
35,000
30,000
25,000
20,000
15,000
10,000
5,000
0
1965
1970
1975
1980
Independence
1965
S$ 1,567
(1965)
History | KBE | Biomed | S&E | Talent | Enterprise
1985
1990
1995
2000
2005
S$14,345
(1986)
1986: Economy grew 2%
1987: Economy grew 9%
1988: 20,000 new jobs created
Building the Data Storage Industry Cluster
Cumulative Output (1986-2000): S$170 billion
S$ Mil
25,000
S$20 billion
(1997)
20,000
15,000
S$11 billion
(2006)
10,000
5,000
0
1982
S$2.4 billion
(1986)
1984
1986
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
Building the Semiconductor Industry Cluster
Cumulative Output (1986-2000): S$122 billion
S$36 billion
(2006)
40,000
30,000
S$11 billion
(1998)
20,000
10,000
S$2.3 billion
(1986)
2006
2004
2002
2000
1998
1996
1994
1992
1990
1988
1986
1984
1982
1980
0
Building The Chemicals Industry Cluster
S$76 billion
(2006)
Cumulative Output (1986 – 2000) - S$266 billion
S$ Million
50,000
40,000
30,000
Official Opening
of Jurong Island
(S$32 billion)
1995 Construction
started on Jurong Island
(S$17 billion)
60,000
20,000
10,000
1986
1988
1990
1992
1994
History | KBE | Biomed | S&E | Talent | Enterprise
1996
1998
2000
2002
2004
2006
The Jurong Island Story
1991
These seven tiny islands (800 ha in all) then became …..
History | KBE | Biomed | S&E | Talent | Enterprise
present
… a 3,400 ha single island
Jurong Chemical Island ….Today
Jurong Island Today
… a 3,400 ha single
island
2006 GDP Pie (S$210 billion)
5.2%
(Others)
10.2%
(Other Services)
27.7%
(Manufacturing)
Manufacturing
Construction
Wholesale & Retail Trade
11.5%
(Business Svcs)
Transport & Storage
Hotels and Restaurants
Information & Communications
3.6%
Financial Services
(Construction)
Business Services
11.2%
Other Services
(Financial Svcs)
Others
3.8%
(Info &
Comms)
1.9%
(Hotels &
Restaurants)
15.2%
9.6%
(Transport &
Storage)
History | KBE | Biomed | S&E | Talent | Enterprise
(Wholesale &
Retail Trade)
Manufacturing
Total Manufacturing Output of 4 key clusters :
$235 billion (2006)
S$ Million
100,000
Electronics
Chemicals
80,000
60,000
40,000
Precision Engrg
20,000
Biomedical Sciences
0
1986 1988 1990 1992
1994 1996 1998
Electronics (incl Data Storage and Semiconductors)
History | KBE | Biomed | S&E | Talent | Enterprise
2000 2002 2004 2006p
Chemicals
BMS
Precision Engrg
Manufacturing
Total Employment in 4 clusters : 223, 277 (2006)
Person
140000
120000
Electronics
100000
Precision
Engrg
80000
60000
40000
Chemicals
20000
Biomedical
Sciences
0
1986
1988
1990
Electronics
1992
1994
1996
Chemicals
History | KBE | Biomed | S&E | Talent | Enterprise
1998
BMS
2000
2002
2004 2006p
Precision Engrg
Creation of 4 clusters of growth
Singapore has promoted and attracted 4 waves of investments: * Data storage (1986-1990)
* Semiconductors (1991-1995)
* Chemicals (1996 to 2000)
* Biomedical industries (2001 to 2006)
Four Industry Waves (1986 to 2006)
Data Storage
S$170 b
Semiconductors
S$122 b
Chemicals
S$266 b
Biomedical Sciences
S$125 b
History | KBE | Biomed | S&E | Talent | Enterprise
Where do we go from here?
GDP Per capita (S$)
High Growth
Stagnation
Technology Intensive
Capital Intensive
Skills Intensive
Labour Intensive
History | KBE | Biomed | S&E | Talent | Enterprise
Decline
Moving forward to a Knowledge Based
Economy model
1965 – 1978:
Export Oriented
Industrialisation
1979 – 1985:
Industrial Restructuring
1986 – 2000:
Capability Building and
Economic Diversification
2001 onwards:
Transforming to KnowledgeBased Economy
History | KBE | Biomed | S&E | Talent | Enterprise
From Manufacturing to
Knowledge-Based Economy
• An Economy based on cost efficiency is not
sustainable in the long term
• Move up the Value chain with focus on high valueadded activities
• Graduate Education is a necessity for high valueadded R&D-oriented industries
• Research  Development  Production 
Marketing  Distribution  Servicing
History | KBE | Biomed | S&E | Talent | Enterprise
What is a Knowledge-Based Economy?
Create, Own + Exploit (COE) Knowledge

How do we create knowledge and useful ideas? R&D
and innovation.

Where? New high growth areas like biomedical
sciences, nanotechnology, energy.

Why? R&D generates intellectual property (IP) and this
is the “real value-added” R&D complements our manufacturing
core. Coupling the two will create clusters of high value-added
activity.
History | KBE | Biomed | S&E | Talent | Enterprise
Building up the R&D foundation (2001)
Biomedical
Research
Council
Science and
Engineering
Research
Council
A*STAR
Graduate
Academy
History | KBE | Biomed | S&E | Talent | Enterprise
Exploit
Technologies
Corporate
Planning and
Administration
A*STAR’s Foundations
Research governance framework
* Established Research Councils and RI Scientific
Advisory Boards
Research
governance framework
Research Infrastructure
* Completed Biopolis Phase 1 & Phase 2
International
Partnerships
Research
Infrastructure
Focus on Talent
* Attracted international scientific leaders and
scientists
* Set up A*STAR Graduate Academy to groom
Singaporean PhD talent
Commercialisation
Talent
- Development
Encourage Commercialisation
* Streamlined Intellectual Property policies
* Established Commercialisation of Technology
Fund
International Partnerships
* Partnerships for research collaboration and
History | KBE | Biomed | S&E | Talent | Enterprise
graduate education/training
A snapshot of Singapore’s current R&D scene
History | KBE | Biomed | S&E | Talent | Enterprise
International Comparison of R&D Intensity
Singapore’s Goal: 3.0% by 2010
Limit: TALENT
R&D / GDP %
4
Finland
3.5
Japan
3
Korea
United States
Taiwan
2.5
Total OECD
Singapore
2.36% (2005)
2
1.5
Singapore
1.88%
(2000)
Ireland
1
2000
2001
2002
2003
2004
Year
Source: National Survey of R&D in Singapore 2005 and OECD MSTI 2006_1
History | KBE | Biomed | S&E | Talent | Enterprise
2005
Building up R&D Human Capital
2000 - 2006
28000
130
110
24000
22000
90
20000
70
18000
16000
50
14000
30
12000
10000
10
2000
2001
2002
2003
2004
2005
No. of research manpower
No. of research manpower per 10,000 labour force
History | KBE | Biomed | S&E | Talent | Enterprise
2006
RSE per 10,000
Research Scientists and Engineers (RSE)
26000
No. of Patents Applied / Awarded
Goal
2200
2000
1800
1600
1400
1200
1000
800
600
400
200
0
2000
2001
2002
2003
Patents applied
Patents awarded
History | KBE | Biomed | S&E | Talent | Enterprise
2004
2005
2006
Building up Biomedical Sciences
2001
A*STAR
History | KBE | Biomed | S&E | Talent | Enterprise
Vision
Singapore – The Biopolis of Asia
Basic,
Translational
& Clinical
Research
Product &
Process
Development
Pilot &
Commercial
Manufacturing
Regional HQ &
Shared Services
Healthcare
Delivery
An International Biomedical Sciences Cluster
Advancing Human Health
Through the Pursuit of Excellence in
Research & Development, Manufacturing, and Healthcare Delivery
History | KBE | Biomed | S&E | Talent | Enterprise
Biomedical Sciences Value Chain
Research
Development
S*BIO
Human Capital
Development
Intellectual
Capital
Development
History | KBE | Biomed | S&E | Talent | Enterprise
Manufacturing
Healthcare
Services
Industrial Capital
Development
How It All Started….
Prof. John Wong
Prof. Tan Chorh Chuan
A/Prof. Kong Hwai Loong
BMS International Advisory Council
Sir Richard Sykes (Chairman)
Imperial College (UK)
Dr Sydney Brenner
The Salk Institute
(USA)
Dr Leland Hartwell
Fred Hutchinson Cancer
Research Center (USA)
Dr Peter Gruss
Max Planck Society
(Germany)
Dr John Bell
University of Oxford
(UK)
Dr Colin Blakemore
Medical Research Council
(UK)
Dr Harriet Wallberg-Henriksson
Karolinska Institutet
(Sweden)
Dr Suzanne Cory
WEHI
(Australia)
Dr William Evans
St Jude (USA)
Dr Helen Hobbs
UT Southwestern
(USA)
Dr Anthony Pawson
Samuel Lunenfeld Research Institute
(Canada)
Dr John Mendelssohn (Co-Chairman)
MD Anderson (USA)
Dr Tadataka Yamada
Gates Foundation
(USA)
Dr Rolf Zinkernagel
University of Zurich
(Switzerland)
Sir Philip Cohen
University of Dundee
(UK)
Dr John Reed (Emeritus)
Burnham Institute
(USA)
Dr David Baltimore (Emeritus)
California Institute of Technology
(USA)
Dr Philippe Kourilsky (Emeritus)
College de France
(France)
Dr Alan Bernstein (Emeritus)
Canadian Institutes of Health
Research (Canada)
Dr Richard Lerner (Emeritus)
Scripps Research Institute
(USA)
Sir George Radda (Emeritus)
University of Oxford
(UK)
Dr Samuel Barondes (Emeritus)
University of California, San
Francisco (USA)
Dr Stanley N. Cohen (Emeritus)
Stanford University
(USA)
Dr David I. Hirsh (Emeritus)
Columbia University
(USA)
Dr Susan Lindquist (Emeritus)
Whitehead Institute of
Biomedical Research (USA)
Dr Paul A. Marks (Emeritus)
Memorial Sloan-Kettering Cancer
Center (USA)
Dr Alan Munro (Emeritus)
University of Cambridge
(UK)
Sir Keith Peters (Emeritus)
GlaxoSmithKline
(UK)
Dr Hans Wigzell (Emeritus)
Karolinska Institutet
(Sweden)
Dr Axel Ullrich (Emeritus)
Max-Planck Institute of
Biochemistry (Germany)
Dr John Shine (Emeritus)
Garvan Institute of Medical
Research (Australia)
Breaking New Ground in 2001 …
Biopolis
History | KBE | Biomed | S&E | Talent | Enterprise
Biopolis
Biopolis Phase 1
Biopolis 1
Biopolis 2
 All 5 BMRC Research Institutes
 S&T offices (British High Com and
RIKEN)
 Corporate labs (NITD, GSK)
 185,000 square metres
 Officially opened on October 2003
Biopolis Phase 2
 BMRC Research Institutes
 Corporate labs
 Additional 37,000 square metres
 Officially opened on 30 October 2006
BMRC Research Institutes
Institute of
Molecular and
Cell Biology
(IMCB)
Bioprocessing
Technology
Institute (BTI)
Bioinformatics
Institute (BII)
Genome
Institute of
Singapore (GIS)
Institute of
Bioengineering &
Nanotechnology
(IBN)
History | KBE | Biomed | S&E | Talent | Enterprise
Institute of
Medical
Biology (IMB)
Singapore
Institute
for Clinical
Sciences (SICS)
Integrated Infrastructure: Tuas Biomedical Park
Biopolis
Tuas Biomedical Park
Phase 4
Phase 3
Shared Facilities
 Shared R&D equipment
 Shared animal facility


Phase 2
37,000 sqm
Opened on 30 October 2006




Phase 1
185,000 sqm
S$500 million invested
Public & corporate R&D labs
> 95% of space committed
History | KBE | Biomed | S&E | Talent | Enterprise
Tuas Biomedical Park I & II
 360 Ha of prepared industrial land
 Ready infrastructure provided
- Stable water, Electricity,
Telecommunications,
Sewerage discharge
Biomedical Sciences (BMS)
Manufacturing Performance 1986-2006
$ ‘000
Cumulative Output (1986 – 2006) - S$125 billion
25,000
S$23 billion
(2006)
20,000
Output
15,000
S$6 billion
(2000)
10,000
5,000
Manufacturing Output
History | KBE | Biomed | S&E | Talent | Enterprise
Value-Added
2006
2004
2002
2000
1998
1996
1994
1992
1990
1988
1986
0
Biomedical Sciences (BMS) Actual
Employment 1986 - 2006
10,572
(2006)
12000
Employment
10000
8000
5,880
(2000)
6000
4000
2000
History | KBE | Biomed | S&E | Talent | Enterprise
2006
2004
2002
2000
1998
1996
1994
1992
1990
1988
1986
0
Biomedical Cluster Map
CLINICAL
RESEARCH
MEDICAL
TECHNOLOGY
PHARMACEUTICALS
Bioprocessing
Chemical Synthesis
Genomics & Proteomics
Industry
Sectors
Molecular & Cell Biology
Industry
Sectors
Bioengineering &
Nanotechnology
HEALTHCARE
SERVICES &
DELIVERY
Computational
Biology
TRANSLATIONAL
RESEARCH
History | KBE | Biomed | S&E | Talent | Enterprise
BIOTECHNOLOGY
Co-investment, VC funding
RISC grants, infrastructure, tax
breaks
INDUSTRY
Pharma
MEaT
Biotech
Overseas
Clinical Trials
Clinical Trials
Singapore Clinical
Trials
Mission-oriented BENCH
Research Institutes
• IMCB, GIS, BTI
• IBN, BII,
• CMM, SICS
Research Consortia
• SBIC
• SSCC
• SIgN
• Biomarkers
Academic BENCH
NUS, NTU
Translational /
Investigational
Medicine
Set up by
A*STAR / BMRC
STN
SCS
DPF Office
SCCS
MBBS PhD / BMS IF /
CSI awards
MEaT = Medical Enginering and Technology
IMCB = Institute of Molecular & Cell Biology
GIS = Genome Institute of Singapore
BTI = Bioprocessing Technical Institute
IBN = Institute of Bioengineering and Nanotechnology
BII = Bioinformatics Institute
CMM = Centre for Molecular Medicine
SICS = Singapore Institute for Clinical Sciences
SBIC = Singapore Bioimaging Consortium
BEDSIDE
NMRC / HSA
Clinical Research Programmes
• Focus, strategy
Human Capital
• Development, recruitment
Infrastructure
• For Clinical Trials
Regulatory Framework
• IRBs
SIgN = Singapore Immunology Network
SSCC = Singapore Stem Cell Consortium
STN = Singapore Tissue Network
SCS = Singapore Cancer Syndicate
SCCS = Singapore Consortium of Cohort Studies
DPF
= Data Privacy Framework
BMS IF = Biomedical International Fellowship
CSI
= Clincian Scientist Investigatorship
IRBs = Institutional Review Boards
Basic
BIOMEDICAL RESEARCH
Translational
Clinical
A*STAR Biomedical Research
Research Institutes
• Institute of Molecular &
Cell Biology
• Genome Institute of
Singapore
Institute of Medicinal Biology
(IMB)
CMM @ Biopolis
(2006 -2008)
− Singapore Oncogenome Group
− Regenerative Medicine
− Epithelial Biology
• Institute of
Bioengineering &
Nanotechnology
• Bioprocessing
Technology Institute
• Bioinformatics Institute
Extramural
Grants
Consortia
− Singapore Cancer Syndicate
− Singapore Bioimaging
Consortium
− Singapore Stem Cell
Consortium
− Singapore Immunology
Network
− Member of Intl Cancer
Biomarker Consortium
UNIVERSITIES
Singapore Institute for
Clinical Sciences (SICS)
• Develop programmes in
Translational Clinical Medicine
• Develop critical resources:
- Singapore Tissue Network
- Singapore Consortium of
Cohort Studies
• Develop Clinician Scientists:
- Clinician Scientist
Investigatorship (CSI) Awards
- PhD training for medical
doctors
- Biomedical International
Fellowships
SICS @ Kent Ridge
- Genetic Medicine
- Virology/Infectious Diseases
SICS @ Outram
(2008-2010)
− Cardiovascular Diseases
− Eye Diseases
Ministry Of Health
National Healthcare Group
•
•
•
•
•
National University Hospital
The Cancer Institute
Tan Tock Seng Hospital
Communicable Disease Centre
National Skin Centre
Singapore Health Services
•
•
•
•
•
•
Singapore General Hospital
National Cancer Centre
National Heart Centre
Singapore National Eye Centre
KK Women and Children’s Hospital
National Neuroscience Institute
MOH HQ
- Ethical regulations/framework for
clinical research e.g. IRBs
NMRC
- Clinical research strategy
- Grant management
- Manpower development
- HSA
- Evaluation capabilities for new
technologies
Hub for Clinical Trials & Regional Management
Local: Early Phase and Complex Trials
Bristol-Myers
Squibb Company
 32 emp
 Phase 2-4 Trials
 GSK and GSK
Biologicals
 42 emp
 Phase 2-4 Trials
 22 emp
 Phase 2-4 Trials
 Data Management
 8 emp
 Phase 3 Trials
 Results Used in
NDA Submission
 12 emp
 Phase 2-3 Trials
 Centralized Data
 4 emp
 Phase 2-4 Trials
 Data Management
 6 emp
 Phase 2-3 Trials
 Results Used in
NDA Submission
 10 emp
 Phase 2-4 Trials
 14 emp
 Phase 1-4 Trials
 10 emp
 Phase 3-4 Trials
LILLY
 20 emp
 28 Bed Phase 1 Unit
 Phase 3-4 Trials
 65 emp
 31 bed Phase 1
Unit
 Japan Bridging
Studies
History | KBE | Biomed | S&E | Talent | Enterprise
Fusion of Science and Engineering
History | KBE | Biomed | S&E | Talent | Enterprise
Science&and
Engineering
Cluster
Map
Science
Engineering
Industry
Clusters
ELECTRONICS
Advanced Display
Electronic Components
IME
DSI
I2R
Communications
Data
Storage
Digital Content & Media
Microelectronics
Devices
Electronic Modules
Semiconductors
INFOCOMM
Storage & Peripherals
Software & Computing
Computational Science
Manufacturing Technology
Material Science & Engineering
Infocomm Research
Specialty Chemicals
Chemical
Sciences
Performance Materials
Petroleum/Petrochemicals
Bio & Consumer Chemistry
Process Engineering *
IMRE
ICES
SIMTech
IHPC
Precision Components
Precision Modules
Machinery & Systems
Aerospace
Marine & Offshore
Automotive
CHEMICALS
ENGINEERING
Alignment of SERC RIs to meet Industry Needs
History | KBE | Biomed | S&E | Talent | Enterprise
Developing New Competencies
ELECTRONICS
INFOCOMM
Imaging
Advanced Display
Nano-elect.
Polymer Elec.
Photonics
Communications
Electronic Components
Electronic Modules
Data
Storage
Semiconductors
MicroElectronics
Storage & Peripherals
Info-Comm Sciences
Software &
Computing
Ultra wide
Band
Digital Content &
Media
Home 2015
Devices
Materials Sciences
Chemical Sciences
Nanotechnology
Human-factor
Engineering
Manufacturing Technology
Human-machine interface
Arrayed sensor networks
Specialty Chemicals
Performance Materials
Petroleum/Petrochemicals
Bio & Consumer Chemistry
Precision
Components
Precision
Machinery
& Systems
Modules
Synthetic
Chemistry
Aerospace
Offshore Engrg
Process Engineering
Sensors
Mfg
Systems
ENGINEERING
CHEMICALS
Energy
History | KBE | Biomed | S&E | Talent | Enterprise
SERC Research Institutes
Data
Storage
Institute
(DSI)
Institute of
Microelectronics
(IME)
Institute for
Chemical &
Engineering
Sciences (ICES)
Institute for
Infocomm
Research (I2R)
Institute of High
Performance
Computing
(IHPC)
History | KBE | Biomed | S&E | Talent | Enterprise
Singapore
Institute of
Manufacturing
Technology
(SIMTech)
Institute of
Materials Research
& Engineering
(IMRE)
Attracting and Anchoring Corporate
R&D activities
SERC RIs initiated
838 Industry R&D projects from FY01-FY06*
* As of 31st December 2006
History | KBE | Biomed | S&E | Talent | Enterprise
Fusionopolis – Home for Integration of
Technologies and Capabilities
Platform (SIMTech / IME)
Technologies
(SIMTech)
System Integration
Systems / Applications (I2R)
Devices
(IME, DSI)
Materials (IMRE)
Central Facilities
History | KBE | Biomed | S&E | Talent | Enterprise
Computer
Modeling (IHPC)
Chemistry (ICES)
Fusionopolis Phase 1 Facilities
SERC, CPAD, ETPL, I2R, IHPC, DSI (network storage), SIMTech (Industrial
Informatics) located at Fusionopolis Phase 1
History | KBE | Biomed | S&E | Talent | Enterprise
Realising Fusionopolis
A Magnet for the
Best and Brightest
Outstanding researchers with diverse
cultures to create highly
inventive environment
Bringing Technology
From the labs to
Your Daily Experience
experimental place to innovate
and create ideas
for R&D and new applications
Singapore’s most
powerful Computers
- driving innovations
Science meets business
Partnering industry in joint
development of next
generation technologies
S'pore's largest R&D
cleanroom at your service
State-of-the-art cleanroom
Small Matters!
produce high-resolution,
3D images down
to an atomic level
Area of Phase 1 : 120,000m2
Area of Phase 2 : 103,688m2
No. of Researchers : > 1600
Integration of SERC RI Capabilities
One-North
FUSIONpolis
– Aerial view
Co-location
of Fusionopolis
and Biopolis
Circle line MRT
History | KBE | Biomed | S&E | Talent | Enterprise
HUMAN CAPITAL
make up a KnowledgeBased Economy (KBE)
History | KBE | Biomed | S&E | Talent | Enterprise
Human Capital - Whales
History | KBE | Biomed | S&E | Talent | Enterprise
Attracting International Talent (Whales)
When physician-scientists Judith Swain and
Ed Holmes take up their posts in
Singapore…, they will join a star-studded
community at one of the world’s most
rapidly developing biomedical research
centres. …they are the latest of many
Western scientists who have headed for
the impressive facilities of the tiny citystate.
Sir David Lane
Executive Director, IMCB & Executive
Dy Chmn (BSTG), BMRC
Dr Judith
Swain
Executive
Director, SICS
Naturejobs, 5 Jul 06
Sir George Radda
Chairman, SBIC
Dr Edison Liu
Executive Director,
GIS
2001
Dr Yoshiaki Ito
PI, IMCB
2002
Dr Jackie Ying
Executive
Director, IBN
2003
Dr Edward Holmes
Executive Dy Chmn
(TCSG), BMRC &
Chmn, NMRC
Dr Axel Ullrich
Director, SOG Lab
2004
History | KBE | Biomed | S&E | Talent | Enterprise
Dr Birgitte Lane
Executive
Director, IMB
Dr Neal Copeland &
Dr Nancy Jenkins
PIs, IMCB
2005
Dr Philippe Kourilsky
Chairman, SIgN
Dr Phil Ingham
PI, IMCB
Dr Jean Paul
Thiery
PI, IMCB
2006
Human Capital - Guppies
History | KBE | Biomed | S&E | Talent | Enterprise
Nurturing & Developing Human Capital (Guppies)

10-14 yrs
Youth
Science
15-18 yrs
YRAP &
JC Awards
19-23 yrs
NSS(BS)
History | KBE | Biomed | S&E | Talent | Enterprise

24-30 yrs
NSS(PhD)
AGS
Young
Whales
Senior
Guppies
Guppies
Talent Pipeline

< 35 yrs
IF(MD)
Nurturing & Developing Human Capital
A*STAR SCHOLARSHIPS
National Science
Scholarships
(NSS)
A*STAR Graduate
Scholarships
(AGS)
National University of Singapore
BS
(3 years)
Nanyang Technological University
PhD
(3-5 years)
Imperial College London, UK
University of Illinois, UrbanaChampaign, USA
(8 years)
MBBS-PhD
International
Fellowship (IF) for (1-2 years)
Medical Doctors
Karolinska Institutet, Sweden
University of Dundee, UK
Carnegie Mellon University, USA
University of Cambridge, UK
History | KBE | Biomed | S&E | Talent | Enterprise
Human Capital: International Guppies
MIT
Physics
(Malaysia)
MIT
Chemical Engineering
(Germany)
Stanford
Chemical Engineering
(Shanghai)
MIT
Bio Engineering
(Hong Kong)
Stanford
Computer Science
(India)
MIT
Chemical Engineering
(Vietnam)
Human Capital: Singapore Guppies
Rockefeller
Bacteriology
Medicine/PhD
Duke
Stanford
Biochemistry
Medicine/PhD
Camrbidge, London
Stanford
Biochemistry
Computer Science
Carnegie-Mellon
International Linkages
History | KBE | Biomed | S&E | Talent | Enterprise
A*STAR Partners in PhD Training
LOCAL
OVERSEAS
•
•
•
•
PhD studies in Biomedical Sciences, Physical Sciences and Engineering
Scholars are supervised throughout their course of study
Upon completion, Scholar is awarded PhD degree from the respective
university
Promotes collaborations between A*STAR Research Institutes & Universities
History | KBE | Biomed | S&E | Talent | Enterprise
Nurturing & Developing Human Capital
695 Potential and Completed PhDs
NSS(PhD) - 4-5 yrs
NSS(BS) - 3 yrs
200
overseas
46 Completed
PhDs
232*
AGS - 4 yrs
217 at partner
universities
7
History | KBE | Biomed | S&E | Talent | Enterprise
IF
55
Completed
Correct as at 25 July 2007
•Of which, 70 BS and 1 MBBS are NSFs.
Completed PhDs
Ang
Hwee
Ching
Biomedical
Sciences
(30)
Koh
Kian
Peng
Ho Han
Kiat
Keefe
Chng
Science &
Engineering
(16)
Tracy
Ho
As of July 07
Yeo
Sze
Ling
Foo
Yong
Lim
Anwesha
Dey
Chow
Keat
Theng
Lim
Chin
Yan
Low
Yen
Ling
Max
Fun
Ng
Sean
Pin
Andrew
Wan
Amanda
Chan
Wee
Boon
Yu
Teo
Hsiang
Ling
Leong
Siang
Huei
Chan
Kok
Ping
Chit
Fang
Cheok
Quek
Su Ying
Yuen
Chau
Cleo
Choong
Leong
Li
Ming
Gary
Ng
Sum
Huan
Chua
Yang
Choo
Ho Ying
Swan
Andrea
Pillai
Ng
Ching
Ging
Ng
Kee
Woei
Zhang
Rui
Wong
Ee
Tsin
Loo
Li
Shen
Andrew
Ang
Ng San
San,
Susanne
Yeo
Yong
Kee
Yar Kar
Peo
Tng Hui
Ching,
Emilia
Chaw
Kwan
Chun
Even More to Return with PhDs
Projected No. of Returning PhD Scholars
160
135
140
125
120
120
107
100
89
82
80
65
59
60
55
54
54
42
35
40
22
20
27
27
2020
2021
11
0
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Correct as at 1 August 2007
Based on reaching annual scholarship targets up to 2010, and 10% attrition rate of NSS(BS) moving onto to PhD
• 33 Completed PhDs returned in 2005-06.
• 59 projected to return in 2007, of which 13 have already been deployed.
• 80 projected to return annually on average from 2011.
R&D
Intellectual
Property
LOCAL ENTERPRISE
DEVELOPMENT
History | KBE | Biomed | S&E | Talent | Enterprise
Sustainable
Vibrant
Economy
Small & Medium Enterprises (SMEs)
• 46% of GDP and 63% of employment
• Local SMEs: 25% of GDP and 51% of employment
• Small is NOT Beautiful. Few small enterprises survive
in the long term
• Elephants can Dance
• Challenges:
 How to sustain broad-based economic growth?
 How to encourage Innovation and Creativity?
History | KBE | Biomed | S&E | Talent | Enterprise
Contribution of Local SMEs (2005)
• Share of Enterprises
• Contribution to GDP
• Contribution to Employment
Local SMEs
90.8%
25.4%
51.0%
Foreign SMEs
8.6%
20.5%
11.5%
All SMEs
99.4%
45.9%
62.5%
Enterprises
Value Added
percent
percent
8.9
10
8
6
percent
80
75.1
12
3.8
34.8
19
2
20
0
0
Manufacturing (Local SMEs)
7.3
8
40
4
10.7
10
60
5
Employment
6
4
2.6
2
0
Services (Local SMEs)
Others (Local SMEs)
Note: SMEs are defined as enterprises with 30% or more local equity ownership, with net fixed assets
investment of $15mil or less for manufacturing industries, and enterprises with 200 or less employees
for service industries.
History | KBE | Biomed | S&E | Talent | Enterprise
Number of Local Enterprises in Manufacturing & Services Sectors
~ 100,000 micro-sized enterprises; 20,000 Small & Medium-Sized Enterprises
Local Manufacturing
SMEs (2005)
All Ind.
SPRING’s
Verticals
All Ind.
SPRING’s
Verticals
All Ind*.
SPRING’s
Verticals
< $1m
4,589
4,582
96,006
37,329
100,595
41,911
$1m - <$10m
2,226
2,211
14,766
3,738
16,992
5,949
$1m - <$5m
1,789
1,779
12,765
3,346^
14,554
5,125^
$5m - <$10m
437
432
2,001
392^
2,438
824^
$10m - <$50m
369
353
1,745
222
2,114
575
$10m - <$25m
281
269
1,281
143^
1,562
412^
$25m - <$50m
88
84
464
79^
552
163^
Sub-total
(<$50m):
7,184
7,146
112,517
41,289
119,701
48,435
$50m & above
68
65
400
26^
468
91^
Total:
7,252
7,211
112,917
41,315
120,169
48,526
Size of
Enterprises
Sales Revenue
Micro
Small
Medium
Large+
Total
Local Services
SMEs (2004)
Source: EDB & DOS; excluded NPOs
Notes: ^ Figures are SPRING’s estimates
+ This group of enterprises meet the SMEs’ definitions and are eligible for SME incentives
* Excludes local SMEs in Construction, Utilities, Agriculture and Fishing (approx. 15,600 in 2005)
Broad-based:
EnterpriseOne
with chambers
& major
associations
Industry-led:
LEAD Prog
with industry
associations
Focused
Support for
Growth
Enterprises
“EVERY GREAT OAK TREE STARTED AS A
DETERMINED ACORN”
Acorn
TO HAVE A FOREST OF OAK TREES, WE
NEED TO SEED MANY (SURVIVING) ACORNS!
Oak Trees
History | KBE | Biomed | S&E | Talent | Enterprise
Nurturing,
Grooming –
“Work of
economic
agencies”
Oak Trees – “Future
economic prosperity”
Young ACORNs –
“New Enterprises,
Start-ups”
“Economic Decline”
BIRTH
An acorn that does not grow up is a dead acorn !
History | KBE | Biomed | S&E | Talent | Enterprise
The Economy is a dynamic Pyramid
Global
Enterprises
Large Enterprises
(output > $50 million)
Medium Enterprises
(output < $50 million)
Small Enterprises
(includes young start-ups)

History | KBE | Biomed | S&E | Talent | Enterprise
What Small and Medium
Enterprises (SMEs) need ?
Global
Enterprises
Money
Markets
Large Enterprises
(output > $50 million)
Know How/What
Medium Enterprises
(output < $50 million)
Management
Small Enterprises
(includes young start-ups)
History | KBE | Biomed | S&E | Talent | Enterprise
The 3MK Strategy
Money
Partner MAS and Financial
Institutions
to enhance SMEs’
access to financing
Markets
Partner IE and EDB
to increase
overseas market access
History | KBE | Biomed | S&E | Talent | Enterprise
Know-how /
Know-what
Partner A*STAR, Universities and
Polytechnics to help companies
acquire & adopt technologies to
innovate and grow
Management
Partner Universities to upgrade
management competence
Enhance SME Financing
Guiding principles
Provide
Complementary
Sources of Financing
$$$
for SMEs
Educate
and
Raise Awareness
Review
Regulations
1) Private sector is
primary source of funds
2) Government plays
catalytic role where
there are gaps
3) Involve private sector
partners
Improve Access to Overseas Markets

Facilitate access to Global markets

Link SMEs to MNCs and foreign SMEs

Provide Export Technical Assistance
History | KBE | Biomed | S&E | Talent | Enterprise
Enhancing Know-how / Know-what
SMEs
A*STAR
• Individual companies
• Consortia
• Industry
• Research Institutes
• Universities
• Polytechnics
• Technology service
providers
SPRING
• Catalyze projects
• Promote awareness
• Partial funding
•IES
•EDB
Knowledge Centres
Technology Innovation Programme (August 2007)
$150m over 5 years to help local SMEs compete on technology, not just cost.
SMEs can tap on knowledge centres to innovate
History | KBE | Biomed | S&E | Talent | Enterprise
Upgrade Management Skills
Management Development Programme (April 2007)
• Co-fund and train 1,000 SME CEOs and Managers
over 5 years
• Funded local Universities to develop curriculum for
SMEs
• EMBA and Executive Development courses
History | KBE | Biomed | S&E | Talent | Enterprise
3G – Grow, Glow and Globalise
EDB
Global
Enterprises
A*STAR
- Generating Know How
- Attracting Overseas
Investments
Large Enterprises
(output > $50 million)
IE Singapore
- Oversee Markets Access
- Attracting Whales (Talent)
Medium Enterprises
(output < $50 million)
SPRING
Small Enterprises
(includes young start-ups)
History | KBE | Biomed | S&E | Talent | Enterprise
- Enterprise development
Key Challenges for Singapore
• Face Global Competition
• Transit from Manufacturing
to “know-how”, a Knowledge
Based Economy (KBE)
• Nurture an Enterprise culture:
- Passion (risk taking)
- Determination (hard work)
- Vision (Global)
- Focus (Operational)
History | KBE | Biomed | S&E | Talent | Enterprise